Doug White joined Emergent in 2017 and serves as head of the devices business unit. He previously served as vice president and general manager of Molecular Diagnostics & Women’s Health at Becton Dickenson Diagnostics. Before joining Becton Dickenson Diagnostics, he was chief executive officer of OpGen Inc.
Paul Nolde has close to two decades of experience in the banking, finance, and venture capital sectors, serving in multiple business development and management roles. As the Fund Manager and Managing Director of Riverflow Growth Fund, a seed-stage venture capital fund based in Richmond, VA, Paul is responsible for all aspects of fund management and investment-related processes.
Rachel is the Director of the BARDA Alliance for Johnson & Johnson Innovation, based at JLABS @ Washington, DC. In this role, she is responsible for managing the BLUE KNIGHT™ collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA). BLUE KNIGHT™ focuses on addressing public-health threats and emerging infectious diseases by supporting companies with emerging science and technology solutions that aim to improve health security and responses.
Numerous bacterium, viruses, fungi, and parasites can cause serious infections in people, and Virginia-based Aperiomics aims to catalog each one to provide doctors with the most accurate diagnostics information available.
Rockville, Maryland’s Advanced BioScience Laboratories, Inc. (ABL) is a rapidly growing biotech company that provides expert contract manufacturing and laboratory research services to customers across the globe. The company delivers best-in-class GMP manufacturing and immunology solutions for gene therapies, oncolytics, vaccines, and other immunotherapeutics to life science organizations, and government agencies.
TEDCO CEO Troy LeMaile-Stovall believes the growth of the life sciences ecosystem in Maryland requires a greater sense of cohesion.
At BioBuzz, we’re dedicated to bringing you interesting and important stories that emerge from the thriving life sciences ecosystem that is the BioHealth Capital Region (BHCR).
Maryland is the epicenter of biotech and life science innovation in the BioHealth Capital Region (BHCR). The state is home to a burgeoning life science ecosystem, including a rapidly growing cell and gene therapy industry, a robust and growing advanced biomanufacturing environment, and a deep network of leading research universities and critical government life science research entities.
4 Key Insights for Startups and Entrepreneurs Looking to Grow a Life Science Business BioHealth Capital Region Key Opinion Leaders and Connectors Share Thoughts on Growing the Region’s Innovation Ecosystem [….]
Winner of Innovation Challenge Delivers Unique Population Health Insights for Healthcare and Life Science June 18, 2019 Earlier this month, Socially Determined won the LifeBridge Health and CareFirst Innovation Challenge. [….]
